Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Denroche

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Plos Computational Biology|January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancerDeena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Scientific Reports|May 20, 2021
Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancersNhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?Yifan Wang, Adeline Cuggia, Yen-I Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic CancerJoanna M Karasinska, James T Topham, Steve E Kalloger, et al.
Frontiers in Oncology|May 13, 2022
Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaBryn Golesworthy, Yifan Wang, Amanda Tanti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic CancerGrainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Molecular Cancer Therapeutics|June 11, 2020
Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer TypesJames T Topham, Emma Titmuss, Erin D Pleasance, et al.
Gastroenterology|February 1, 2021
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaTalia Golan, Grainne M O'Kane, Robert E Denroche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular CharacteristicsJames T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Plos Computational Biology|January 11, 2019
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancerDeena M A Gendoo, Robert E Denroche, Amy Zhang, et al.
Scientific Reports|May 20, 2021
Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancersNhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?Yifan Wang, Adeline Cuggia, Yen-I Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic CancerJoanna M Karasinska, James T Topham, Steve E Kalloger, et al.
Frontiers in Oncology|May 13, 2022
Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaBryn Golesworthy, Yifan Wang, Amanda Tanti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic CancerGrainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Cancer Discovery|July 14, 2023
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical SettingChani Stossel, Maria Raitses-Gurevich, Dikla Atias, et al.
Molecular Cancer Therapeutics|June 11, 2020
Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer TypesJames T Topham, Emma Titmuss, Erin D Pleasance, et al.
Gastroenterology|February 1, 2021
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaTalia Golan, Grainne M O'Kane, Robert E Denroche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular CharacteristicsJames T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Pageof 4